Daniela Simone Grumme

Mrs. Daniela Simone Grumme


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2026 in Vaccines
Verified
Journal Article
Open access
PDF file
LMLiza Marie Maus
Liza Marie Maus
DGDaniela Simone Grumme
Daniela Simone Grumme
AGAlexander Gluschko
Alexander Gluschko
KWKatja Wiegmann
Katja Wiegmann
AKAlexander Klimka
Alexander Klimka
MKMartin Martin Krönke
Martin Martin Krönke
Background: Staphylococcus aureus (S. aureus) remains a major global pathogen causing a wide spectrum of diseases. Human adults harbor circulating antibodies against most staphylococcal antigens, which provide little protection against invasive S. aureus infection. Conventional S. aureus vaccines are poised to predominantly repeat the natural, non-protective antibody responses. Objective: We investigated the immunological feasibility of an epitope-focused vaccine targeting the D3 epitope of coproporphyrinogen III oxidase (CgoX), which is recognized by the protective monoclonal antibody anti-CgoX-D3. Methods: The potential of the D3 epitope to break the dominant but non-protective immunity to CgoX was investigated in laboratory mice. The seroprevalence of antibodies against the D3 epitope was investigated in sera from healthy blood donors and patients with S. aureus bacteremia. Results: All sera from 204 healthy blood donors harbored antibodies against CgoX, whereas only 10.3% contained antibodies against the D3 epitope, indicating its immunological subdominance. In patients with invasive S. aureus infection, D3-specific responses were more frequent but remained at low serum concentrations, confirming the quantitative subdominance of the protective D3 epitope. Prime-boosting experiments in mice with combinations of whole CgoX and a CRM197-CgoX-D3 conjugate (D3-CRM) revealed that mice primed and boosted with whole CgoX developed weak D3-specific responses. Boosting CgoX-primed mice with D3-CRM resulted in the generation of robust titers of high-affinity D3 binding antibodies. Conclusions: The immunization history with CgoX markedly influences subsequent D3-specific antibody responses. Epitope-focused vaccination with D3-CRM can overcome the attenuation associated with prior CgoX immunization and elicit high-affinity D3-specific antibodies.